全文获取类型
收费全文 | 185篇 |
免费 | 32篇 |
国内免费 | 5篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 11篇 |
基础医学 | 27篇 |
口腔科学 | 3篇 |
临床医学 | 21篇 |
内科学 | 61篇 |
皮肤病学 | 7篇 |
神经病学 | 2篇 |
特种医学 | 3篇 |
外科学 | 15篇 |
综合类 | 14篇 |
预防医学 | 17篇 |
眼科学 | 2篇 |
药学 | 20篇 |
中国医学 | 5篇 |
肿瘤学 | 9篇 |
出版年
2024年 | 1篇 |
2023年 | 6篇 |
2022年 | 2篇 |
2021年 | 9篇 |
2020年 | 14篇 |
2019年 | 16篇 |
2018年 | 5篇 |
2017年 | 14篇 |
2016年 | 12篇 |
2015年 | 15篇 |
2014年 | 15篇 |
2013年 | 29篇 |
2012年 | 19篇 |
2011年 | 16篇 |
2010年 | 15篇 |
2009年 | 11篇 |
2008年 | 5篇 |
2007年 | 11篇 |
2006年 | 3篇 |
2005年 | 2篇 |
2004年 | 2篇 |
排序方式: 共有222条查询结果,搜索用时 15 毫秒
1.
2.
Stefan Konigorski Yildiz E. Yilmaz Jürgen Janke Manuela M. Bergmann Heiner Boeing Tobias Pischon 《Genetic epidemiology》2020,44(1):26-40
In genetic association studies of rare variants, the low power of association tests is one of the main challenges. In this study, we propose a new single-marker association test called C-JAMP (Copula-based Joint Analysis of Multiple Phenotypes), which is based on a joint model of multiple phenotypes given genetic markers and other covariates. We evaluated its performance and compared its empirical type I error and power with existing univariate and multivariate single-marker and multi-marker rare-variant tests in extensive simulation studies. C-JAMP yielded unbiased genetic effect estimates and valid type I errors with an adjusted test statistic. When strongly dependent traits were jointly analyzed, C-JAMP had the highest power in all scenarios except when a high percentage of variants were causal with moderate/small effect sizes. When traits with weak or moderate dependence were analyzed, whether C-JAMP or competing approaches had higher power depended on the effect size. When C-JAMP was applied with a misspecified copula function, it still achieved high power in some of the scenarios considered. In a real-data application, we analyzed sequencing data using C-JAMP and performed the first genome-wide association studies of high-molecular-weight and medium-molecular-weight adiponectin plasma concentrations. C-JAMP identified 20 rare variants with p-values smaller than 10−5, while all other tests resulted in the identification of fewer variants with higher p-values. In summary, the results indicate that C-JAMP is a powerful, flexible, and robust method for association studies, and we identified novel candidate markers for adiponectin. C-JAMP is implemented as an R package and freely available from https://cran.r-project.org/package=CJAMP . 相似文献
3.
Farnaz Sepandar Maryam Daneshpazhooh Mahmoud Djalali Hamed Mohammadi Elham Yaghubi Zahra Fakhri Hajar Tavakoli Ehsan Ghaedi Ali Keshavarz Mahnaz Zarei Mohammad Amin Shahrbaf Narges Ghandi Mina Darand Mohamad Hassan Javanbakht 《Phytotherapy research : PTR》2020,34(4):859-866
Pemphigus vulgaris (PV) is a chronic autoimmune disorder with potentially fatal outcomes. The aim of this study was to investigate the effect of l ‐carnitine (LC) on secreted frizzled‐related protein‐5 (SFRP5), omentin, visfatin, and glycemic indices in PV patients under corticosteroid treatment. In this randomized, double‐blind, placebo‐controlled clinical trial, 52 patients with PV were divided randomly into two groups to receive 2 g of LC or a placebo for 8 weeks. Serum levels of SFRP5, omentin, visfatin, and also glycemic indices were evaluated at the baseline and end of the study. LC supplementation significantly decreased the serum level of visfatin (95% CI [?14.718, ?0.877], p = .05) and increased the serum levels of SFRP5 (95%CI [1.637, 11.380], p < .006) and omentin (95% CI [9.014, 65.286], p < .01). However, LC supplementation had no significant effects on the serum levels of glycemic factors such as insulin (95% CI [?1.125, 3.056], p = .426), fasting blood sugar (95% CI [?4.743, 3.642], p = .894), homeostatic model assessment of insulin resistance (95% CI [?0.305, 0.528], p = .729), and quantitative insulin‐sensitivity check index (95% CI [?0.016, ?0.010], p = .81). LC supplementation decreased visfatin serum level and increased omentin‐1 and SFRP5 serum levels in patients with PV. However, it has no significant effect on the serum levels of insulin and glycemic indices. 相似文献
4.
张斌山 《中国实验方剂学杂志》2017,23(6):186-191
目的:观察独活寄生汤对风寒湿痹型关节炎患者的疗效,并探讨其对关节液中炎症因子、氧化应激及脂肪细胞因子的影响。方法:选取东莞市中医院诊断及治疗的风寒湿痹型关节炎患者124例,按随机数字表法分组,对照组(62例)予以常规治疗,观察组(62例)在对照组基础上予以独活寄生汤治疗,观察并记录两组患者临床症状评分、关节液指标及脂肪细胞因子水平,同时比较两组患者临床疗效及并发症状况。结果:对照组治疗有效率低于观察组(P0.05);与治疗前比较,两组患者治疗后视觉模拟评分法(visual analogue scale,VAS),西安大略和麦克马斯特骨关节炎调查量表(Western Ontario and Mc Master Universities Osteoarthritis,WOMAC)评分均降低,Lyshom评分升高,关节液中肿瘤坏死因子-α(tumor necrosis factoralpha,TNF-α),白细胞介素-6(interleukin-6,IL-6)及白细胞介素-1β(interleukine-1 beta,IL-1β)表达水平降低,关节液一氧化氮(nitric oxide,NO),丙二醛(malondialdehyde,MDA)水平降低,超氧化物歧化酶(superoxide dismutase,SOD)水平升高,脂联素(adiponectin,APN)水平升高,瘦素(leptin)及内脂素(visfatin)水平降低(P0.05);与对照组比较,观察组治疗后VAS,WOMAC量表评分较低,Lyshom评分较高,关节液TNF-α,IL-6及IL-1β水平较低,关节液NO,MDA水平较低,SOD水平较高,APN水平较高,leptin及visfatin水平较低(P0.05)。结论:独活寄生汤能够使关节炎患者受益,可能与其减少关节液中炎症因子表达及抑制氧化应激有关。 相似文献
5.
Joaquín Portilla óscar Moreno-Pérez Carmen Serna-Candel Corina Escoín Rocio Alfayate Sergio Reus Esperanza Merino Vicente Boix Livia Giner José Sánchez-Payá Antonio Picó 《Journal of the International AIDS Society》2014,17(1)
Introduction
Vitamin D insufficiency (VDI) has been associated with increased cardiovascular risk in the non-HIV population. This study evaluates the relationship among serum 25-hydroxyvitamin D [25(OH)D] levels, cardiovascular risk factors, adipokines, antiviral therapy (ART) and subclinical atherosclerosis in HIV-infected males.Methods
A cross-sectional study in ambulatory care was made in non-diabetic patients living with HIV. VDI was defined as 25(OH)D serum levels <75 nmol/L. Fasting lipids, glucose, inflammatory markers (tumour necrosis factor-α, interleukin-6, high-sensitivity C-reactive protein) and endothelial markers (plasminogen activator inhibitor-1, or PAI-I) were measured. The common carotid artery intima-media thickness (C-IMT) was determined. A multivariate logistic regression analysis was made to identify factors associated with the presence of VDI, while multivariate linear regression analysis was used to identify factors associated with common C-IMT.Results
Eighty-nine patients were included (age 42±8 years), 18.9% were in CDC (US Centers for Disease Control and Prevention) stage C and 75 were on ART. VDI was associated with ART exposure, sedentary lifestyle, higher triglycerides levels and PAI-I. In univariate analysis, VDI was associated with greater common C-IMT. The multivariate linear regression model, adjusted by confounding factors, revealed an independent association between common C-IMT and patient age, time of exposure to protease inhibitors (PIs) and impaired fasting glucose (IFG). In contrast, there were no independent associations between common C-IMT and VDI or inflammatory and endothelial markers.Conclusions
VDI was not independently associated with subclinical atherosclerosis in non-diabetic males living with HIV. Older age, a longer exposure to PIs, and IFG were independent factors associated with common C-IMT in this population. 相似文献6.
Irving L. M. H. Aye Fredrick J. Rosario Theresa L. Powell Thomas Jansson 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(41):12858-12863
Mothers with obesity or gestational diabetes mellitus have low circulating levels of adiponectin (ADN) and frequently deliver large babies with increased fat mass, who are susceptible to perinatal complications and to development of metabolic syndrome later in life. It is currently unknown if the inverse correlation between maternal ADN and fetal growth reflects a cause-and-effect relationship. We tested the hypothesis that ADN supplementation in obese pregnant dams improves maternal insulin sensitivity, restores normal placental insulin/mechanistic target of rapamycin complex 1 (mTORC1) signaling and nutrient transport, and prevents fetal overgrowth. Compared with dams on a control diet, female C57BL/6J mice fed an obesogenic diet before mating and throughout gestation had increased fasting serum leptin, insulin, and C-peptide, and reduced high-molecular-weight ADN at embryonic day (E) 18.5. Placental insulin and mTORC1 signaling was activated, peroxisome proliferator-activated receptor-α (PPARα) phosphorylation was reduced, placental transport of glucose and amino acids in vivo was increased, and fetal weights were 29% higher in obese dams. Maternal ADN infusion in obese dams from E14.5 to E18.5 normalized maternal insulin sensitivity, placental insulin/mTORC1 and PPARα signaling, nutrient transport, and fetal growth without affecting maternal fat mass. Using a mouse model with striking similarities to obese pregnant women, we demonstrate that ADN functions as an endocrine link between maternal adipose tissue and fetal growth by regulating placental function. Importantly, maternal ADN supplementation reversed the adverse effects of maternal obesity on placental function and fetal growth. Improving maternal ADN levels may serve as an effective intervention strategy to prevent fetal overgrowth caused by maternal obesity.Obesity and the metabolic syndrome are major risk factors for a wide array of diseases, including type 2 diabetes mellitus, cardiovascular disease, and cancer (1, 2). Compelling evidence shows that metabolic syndrome is caused, in part, by a suboptimal intrauterine environment (3). The strong association between maternal obesity during pregnancy and metabolic syndrome in childhood is of particular concern because almost two-thirds of American women now enter pregnancy either overweight or obese (4). Obesity during pregnancy therefore creates a vicious, detrimental cycle of intrauterine transmission of metabolic disease from the mother to her children (5). Intervention strategies involving lifestyle changes or antiobesity drugs remain largely unsuccessful, and it is therefore urgent to explore the possibility of intervening in utero to prevent the development of obesity and metabolic syndrome.Obesity in pregnant women is associated with activation of placental insulin and mechanistic target of rapamycin complex 1 (mTORC1) signaling, up-regulation of specific placental amino acid transporters, and fetal overgrowth (6, 7). In addition, circulating levels of adiponectin (ADN) are decreased in obese pregnant women (8, 9). The ADN protein is synthesized in adipose tissue and undergoes tightly regulated multimerization involving chaperone proteins, including disulfide-bond A oxidoreductase-like protein (DsbA-L), resulting in the assembly of oligomeric ADN proteins of different molecular weight (10). Multimerization into the high-molecular-weight (HMW) form increases the t1/2 of ADN (11), and the insulin-sensitizing effect of ADN can largely be attributed to the HMW form (12). Low circulating levels of HMW ADN strongly predict the development of gestational diabetes mellitus (GDM) independent of maternal adiposity (13, 14).We recently reported that ADN, in contrast to its well-known insulin-sensitizing effects in skeletal muscle and liver, inhibits insulin and mTORC1 signaling and amino acid transport in cultured primary human trophoblast (PHT) cells (15) and in pregnant mice in vivo (16). This effect is mediated by activation of trophoblast peroxisome proliferator-activated receptor-α (PPARα) signaling and increased ceramide synthesis, resulting in inhibition of IRS-1 (17). Thus, low circulating ADN in maternal obesity may be causally linked to changes in placental function and increased fetal growth. These findings, together with the recent discovery of an orally active ADN receptor agonist (AdipoRon) (18), provide the rationale for exploring the possibility that maternal ADN supplementation may prevent the adverse fetal outcomes in maternal obesity.We recently established a mouse model of obesity in pregnancy, which shows extensive similarities to the human condition, including low maternal ADN and glucose intolerance, increased placental nutrient transport, and fetal overgrowth (19). In this study, we used this model to test the hypothesis that ADN supplementation in obese pregnant dams improves maternal insulin sensitivity, restores normal placental insulin signaling and nutrient transport, and prevents fetal overgrowth. 相似文献
7.
8.
The concept of food addiction (FA) is a potentially important contributing factor to the development of obesity in the general population; however, little is known about the hormonal and dietary differences between obesity with and without FA. Therefore, the aim of our study was to explore potential biomarkers, including various hormones and neuropeptides, which regulate appetite and metabolism, and dietary components that could potentially differentiate obesity with and without FA. Of the 737 adults recruited from the general Newfoundland population, 58 food-addicted and non-food-addicted overweight/obese individuals (FAO, NFO) matched for age, sex, BMI and physical activity were selected. A total of 34 neuropeptides, gut hormones, pituitary polypeptide hormones and adipokines were measured in fasting serum. We found that the FAO group had lower levels of TSH, TNF-α and amylin, but higher levels of prolactin, as compared to NFO group. The total calorie intake (per kg body weight), the dietary intake of fat (per g/kg body weight, per BMI and per percentage of trunk fat) and the percent calorie intake from fat and carbohydrates (g/kg) was higher in the FAO group compared to the NFO group. The FAO subjects consumed more sugar, minerals (including sodium, potassium, calcium and selenium), fat and its components (such as saturated, monounsaturated and trans fat), omega 3 and 6, vitamin D and gamma-tocopherol compared to the NFO group. To our knowledge, this is the first study indicating possible differences in hormonal levels and micro-nutrient intakes between obese individuals classified with and without food addiction. The findings provide insights into the mechanisms by which FA could contribute to obesity. 相似文献
9.
10.
Local and serum levels of adipokines in patients with obesity after periodontal therapy: one‐year follow‐up 下载免费PDF全文